Immunomodulatory activity of biopolymeric fraction BOS 2000 from Boswellia serrata

Phytotherapy Research

Volumn 22, Issue 3, 2008, Pages 340-348

  Khajuria, Anamika ^a   Gupta, Amit ^a   Suden, Pankaj ^a   Singh, Surjeet ^a   Malik, Fayaz ^a   Singh, Jaswant ^a   Gupta, B D ^a   Suri, K A ^a   Srinivas, V K ^b   Ella, Krishna ^b   Qazi, G N ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^b Bharat Biotech International Limited   (India)

Author keywords

Boswellia serrata; Complement fixing antibody titre; Delayed hypersensitivity reaction

Indexed keywords

BOS 2000; COMPLEMENT FIXING ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOMODULATING AGENT; INTERLEUKIN 4; LEVAMISOLE; NITRITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BOSWELLIA; BOSWELLIA SERRATA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; SERUM; SHEEP ERYTHROCYTE; T LYMPHOCYTE;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; BOSWELLIA; CANDIDA ALBICANS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HYPERSENSITIVITY, DELAYED; IMMUNOLOGIC FACTORS; LEVAMISOLE; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; PHAGOCYTOSIS; PLANT EXTRACTS; SPLEEN;

BOSWELLIA SERRATA; MUS;

EID: 40849097655     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2320     Document Type: Article

References (27)

1. Ammon HP, Mack T, Singh GB, Safayhi H. 1991. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudates of Boswellia serrata. Plant Med 57: 203-207.
2. Bafna AR, Mishra SH. 2006. Protective effect of bioactive fraction of Sphaeranthus indicus Linn against cyclophosphamide induced suppression of humoral immunity in mice. J Ethnopharmacol 104: 426-429.
3. Banerjee SK, Suri OP, Taneja SC et al. 2000. Water-soluble bioactive fraction process for there of from gum resin extract of Boswellia serrata composition containing said bioactive fraction and method for the treatment of arthritis using said fraction. Patent filed in US.
4. Beneacerraf B. 1978. A hypothesis to relate the specific of T lymphocytes and activity of I region specific Ir genes in macrophages and B-lymphocytes. J Immunol 120: 1809-1812.
5. Beutler B. 2004. Innate immunity: an overview. Mol Immunol 40: 845-859.
6. Block KI, Mead MN. 2003. Immune system effects of Echinacea, ginseng, and astragalus: a review. Integr Cancer Ther 2: 247-267.
7. Bourgeois C, Corinne T. 2003. CD4 T cells are required for CD8 T cell memory generation. Eur J Immunol 33: 3225-3231.
8. Dean JH, Singh P, Jerrels TR. 1979. Application of immunocompetence assays for defining immunosuppression. Ann NY Acad Sci 320: 579-590.
9. Fang SP, Tanaka T, Tago F, Okamoto T, Kojima S. 2005. Immunomodulatory effects of Gyokuheifusan on IFN γ/IL-4 (Th1/Th2) balance in ovalbumin (ova) induced asthma model mice. Biol Pharm Bull 28: 829-833.
10. Farrar MA, Schreiber RD. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11: 571.
11. Gupta I, Parihar A, Malhotra P et al. 2001. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med 67: 391-395.
12. Hostanska K, Daum G, Saller R. 2002. Cytostatic and apoptosis-inducing activity of Boswellic acids toward malignant cell lines in vitro. Anticancer Res 22: 2853-2862.
13. Kraus J, Franz G. 1992. Immunomodulating effects of polysaccharides from medicinal plants. Adv Exp Med Biol 319: 299-308.
14. Luis G, Salvador M, Rosa M, Giner M, Carmen R, Jose-Luis R. 2000. On the activity of trifluoperazine and palmitoylcarnitine in mice: delayed hypersensitivity models. Life Sci 66: 183-188.
15. Luster ML, Dean JH, Boorman GA. 1982. Cell mediated immunity and its application in toxicology. Environ Health Perspect 43: 31-36.
16. Mosmann TR, Coffman RL. 1989. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev Immunol 7: 145-173.
17. Mungantiwar AA, Nair AM, Shinde UA et al. 1999. Studies on the immunomodulatory effects of Boerhaavia diffusa alkaloid fraction. J Ethnopharmacol 65: 125-131.
18. Nelson DS, Mildenhall P. 1967. Studies on cytophilic antibodies. 1. The production by mice of macrophage cytophilic antibodies to sheep erythrocytes: relationship to the production of other antibodies and the development of delayed type hypersensitivity. Aust J Exp Biol Med Sci 45: 113-130.
19. Paulsen BS. 2001. Plant polysaccharides with immunostimulatory activities. Curr Org Chem 5: 939-950.
20. Raisuddin S, Zaidi SIA, Singh KP, Ray PK. 1991. Effect of subchronic aflatoxin exposure on growth and progression of Ehrlich's ascites tumor in mice. Drug Chem Toxicol 14: 185-206.
21. Safayhi H, Mack Th, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP. 1992. Boswellic acids: novel, specific, non redox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 261: 1143-1146.
22. Sharma ML, Bani S, Singh GB. 1989. Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int J Immunopharmacol 11: 647-652.
23. Sharma ML, Kaul A, Khajuria A, Singh S, Singh GB. 1996. Immunomodulatory activity of boswellic acids (pentacyclic triterpene acids) from Boswellia serrata. Phytother Res 10: 107-112.
24. Singh GB, Atal CK. 1986. Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions 18: 3/4.
25. Singh GB, Singh S, Bani S. 1996a. Alcoholic extract of salai-guggal ex- Boswellia serrata- anti-inflammatory, anti-arthritic, anti-hyperlipidemic. Drugs Today 32: 109-112.
26. Singh GB, Surjeet S, Bani S. 1996b. Anti-inflammatory actions of boswellic acids. Phytomedicine 3: 81-85.
27. Wang YP, Li XY. 2002. Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice. Acta Pharmacol Sin 3: 263-266.